Confocal imaging of MIN6 in the context of cell proliferation, as well as insulin, C-peptide, and glucagon levels after treatment with investigated leucettines. by Barbara Pucelik (2988795)

Subjects:

The effect of investigated leucettines on the level of DYRK1A in MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

The influence of DYRK1A inhibitors on MIN6 function: Flow cytometry analysis of insulin, C-peptide and glucagon expression in MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

Analysis of the influence of DYRK1A inhibitors on proliferation of INS1E cells. by Barbara Pucelik (2988795)

Subjects:

Protein level calculated in ImageJ from Western blot. by Barbara Pucelik (2988795)

Subjects:

The influence of DYRK1A inhibitors on INS1E function: Flow cytometry analysis of insulin, C-peptide and glucagon expression in INS1E cells. by Barbara Pucelik (2988795)

Subjects:

Relative viability of the INS1E cell lines treated with investigated DYRK1A inhibitors in an MTT assay. by Barbara Pucelik (2988795)

Subjects:

The influence of leucettines as DYRK1A inhibitors on insulin, C-peptide, and glucagon production by MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

Representative confocal images. by Barbara Pucelik (2988795)

Subjects:

The summary of selected properties and biological effects on beta cells determined for leucettine L41, harmine (natural, best-characterized DYRK1A inhibitor) and AC27 (synthetic, s... by Barbara Pucelik (2988795)

Subjects:

The chemical structures of the investigated leucettines. by Barbara Pucelik (2988795)

Subjects:

Prevalence reduction of overall obesity in 2022–2027, according to a decrease in the probability of move up one BMI class and an increase in the probability of move down one BMI class. by Pierre Bauvin (18154818)

“…Scenarios 1 and 2 were built up to obtain a stabilization of the overall obesity prevalence: scenario 1 corresponds to a 22% decrease in the probability of move up one BMI class, and scenario 2 corresponds to a 33% increase in the probability of move down one BMI class. …”

IL-2 level in the aqueous humor. by Ting Zhang (102583)

“…<p>ELISA test demonstrated that IL-2 concentration was significantly increased in the untreated group at 3 weeks, and CsA DDS treatment more effectively decreased the level of IL-2 in the aqueous humors at all time-points. …”

Status of sex, age, BMI and WOMAC in OA patients and healthy controls. by Alireza Askari (2936109)

Subjects:

Correlation between WOMAC pain scores, IL-21, IL-23, IL-17A and vitamin D3 in OA patients. by Alireza Askari (2936109)

Subjects:

Analysis of variables using logistic regression model. by Alireza Askari (2936109)

Subjects:

Serum levels of IL-21, IL-23, IL-17A and vitamin D3 in OA patients in comparison to healthy controls. by Alireza Askari (2936109)

Subjects:

Model for Rbc3a and V0a1 functions in NC cells. by Adam M. Tuttle (560137)

“…In the absence of Rbc3a (or v0a1), canonical Wnt signaling decreases early (∼11 hpf) and increases later (∼20 hpf). …”

Intracellular chlorophyll <i>a</i> concentrations and the fraction of solitary cells in <i>P</i>. <i>antarctica</i> clones under iron replete and iron limited growth. by Katja E. Luxem (1332405)

The expression of mRNA in the iris-ciliary body. by Ting Zhang (102583)

“…<p>Compared with the untreated and CsA eye drop groups, the mRNA levels of IFN-γ, IL-2, IL-6, CD80, and CD86 were significantly decreased, while the transcriptional level of FOXP3 was increased in the CsA DDS group at all time-points. …”